BrainPill

Description of the article « BrainPill »

Quick Answer

BrainPill is a caffeine-free nootropic capsule formula from Leading Edge Health — 13 named ingredients aimed at focus, memory and mental stamina. It is genuinely unusual in this category: the maker ran a real, registered, randomized, double-blind, placebo-controlled trial of the finished product (NCT03198936) and hosts the full report on its own site. But the trial tested 4 capsules a day, while a bottle sold as a one-month supply implies 2 a day; the trial report's own composition table lists only 12 of the 13 marketed ingredients — vinpocetine is missing; and the maker's sales pages overstate what the report found. No ingredient amounts appear on any sales page, and the brand site publishes no safety section. We score it 6.5/10.

Quick Reference

Our Verdict

BrainPill earns the highest credibility marks in this batch for doing the thing almost no competitor does: running a proper trial of its own formula and publishing the full report where anyone can read it. Then its own documents take much of that credit back. The trial dosed 4 capsules a day for 12 weeks; the retail bottle implies 2 a day, and the maker never publishes buyer directions at all, so a customer cannot tell from the maker's site whether the dose they would take matches the dose that was tested. The trial's composition table omits one of the 13 advertised ingredients. The primary result was significant but marginal (p=0.044), one named measure had faded to non-significance by the final day — and the maker's studies page nonetheless announces that "every participant" significantly improved. Buy it, if at all, for the formula's plausible ingredients and the guarantee — knowing the trial's results were obtained at twice the implied retail dose, and that the maker's summary of its own study should not be taken at face value.

Sub-scores

• Ingredients: 7.0/10 — Thirteen recognised nootropics, including two patented branded forms (Cognizin® citicoline and Synapsa® bacopa), docked hard because the maker publishes no amounts on any sales page and its own trial table omits the 13th ingredient.
• Evidence: 6.0/10 — A genuine finished-product, double-blind, placebo-controlled, trial-registered 12-week study is well above the category norm; held back because it is single, small, sponsor-funded, not peer-reviewed as presented, marginal on its primary endpoint, and run at 4 capsules a day. All other maker evidence is ingredient-level and cited without references.
• Maker credibility: 8.0/10 — Leading Edge Health is named on-site, claims a cGMP US facility, publishes written guarantee terms, and — almost unheard of here — hosts its full clinical report publicly. Docked for the internal inconsistencies documented below.
• Safety: 4.5/10 — No safety section on the brand site, a blanket "No Unwanted Side-Effects" claim, and exactly one specific warning (vinpocetine and pregnancy) despite vinpocetine and huperzine A in the formula. The trial's own safety record was clean; the consult-a-doctor line exists only on the maker's secondary retail page.
• Value: 5.0/10 — $69.95 for one month is premium pricing against a maker-stated 30-day minimum and a 30–90-day judging window, while the guarantee covers only about 67 days — and matching the trialled dose would double the monthly cost.

What Is BrainPill?

BrainPill is a daily nootropic capsule from Leading Edge Health, positioned for "success-driven entrepreneurs, high-level executives and serious peak performers" — and, in the maker's FAQ, for adults generally, since "our brains begin to change somewhere in our late 20s or early 30s." It is explicitly caffeine-free and stimulant-free; the maker's benefit list runs to eliminating brain fog, combating mental fatigue, protecting memory, rapid recall, cognitive energy and learning ability, organised as Speed, Defense, Stamina, Memory and Focus. The maker also states who it is not for: anyone "searching for the elusive 'Magic Pill'" or wanting "a cheap, quick 'pick-me-up.'" The maker endorses it through Dr. Dave David, M.D. Timelines differ across the maker's own pages: the homepage says full benefits require at least 30 days; the brand FAQ advises allowing 30 to 90 days; the maker's retail store says most users "hit your stride" between three and six months — and that the guarantee covers roughly the first two bottles of that longer programme.

Key Ingredients

The maker names 13 ingredients and publishes amounts for none of them — no mg or mcg figures and no Supplement Facts panel appear on the brand site or the maker's retail store. The 13, in the maker's grouping: Focus Fuel & Cognitive Energy — Cognizin® (citicoline), Tyrosine, Phosphatidylserine, Vitamin B12, L-Theanine, Vitamin B6, Vitamin B5 (pantothenic acid). Advanced Memory Matrix — Synapsa® (bacopa monnieri extract), Huperzine A, Folic Acid (B9), Vinpocetine, Ginkgo Biloba, DHA Complex.

The only amounts the maker publishes anywhere are in the clinical study report it hosts (see Evidence, below) — and they describe the study regimen of 4 capsules a day (1,185.6 mg/day total): Cognizin® 250 mg, Synapsa® 320 mg, L-Tyrosine 175 mg, Ginkgo Biloba extract 100 mg, Phosphatidylserine 100 mg, DHA Complex 100 mg, L-Theanine 100 mg, Huperzine A 5 mg (as printed), Pantothenic Acid 30 mg, Vitamin B6 5 mg, Vitamin B12 50 mcg, Folic Acid 400 mcg. That table lists 12 ingredients — vinpocetine, marketed everywhere else as one of the 13, does not appear in it at all. The maker does not explain the omission anywhere. So a buyer cannot verify the retail formula's amounts from any sales page, and cannot confirm from the maker's own documents that the trialled formula is the marketed formula.

What We Like

• A real trial of the finished product exists. Randomized, double-blind, placebo-controlled, 12 weeks, registered at clinicaltrials.gov as NCT03198936 and run by a named contract research organisation (Vedic Lifesciences) — a standard of evidence almost nothing else in this category attempts.
• The full report is public. The maker hosts the complete clinical study report on its own site, including the results that do not flatter it. That transparency is exactly what we ask makers for.
• The formula's ingredients are legitimate nootropics — including two patented, branded forms (Cognizin® citicoline, Synapsa® bacopa) rather than anonymous commodity powder.
• Caffeine-free positioning is clear — no stimulant crash claims to untangle, and the maker says so plainly.
• Written guarantee terms — the 67-day terms, including the multi-bottle conditions and the one-order-per-customer limit, are published in full.

Good to Know

• The trial dose is twice the implied retail dose. The study dosed 2 capsules twice a day — 4 a day, with meals, for 84 days. The maker publishes no buyer directions on its web pages at all, and sells a 60-capsule box as a one-month supply, which implies 2 capsules a day — half the tested amount. At the trialled dose, a box lasts about two weeks, which doubles the real monthly cost of replicating the study.
• The maker overstates its own results. Its studies page says that at 12 weeks "every participant using Brain Pill® had a significant increase in cognitive functions." The report itself shows a primary working-memory result of p=0.044 (significant, but marginal), a picture-recognition improvement that was significant at days 28 and 56 but non-significant by day 84 (p=0.476), and a mood score that changed insignificantly in both groups. Read the report, not the headline.
• The report's own numbers vary. Participant counts differ between the report's sections (79 randomized / 74 completed on the title page; 80 randomized / 73 completed in the synopsis), and the maker's studies page says 74 participants. The study was funded by the maker's own sponsor entity (Leading Edge Marketing Ltd) and, as presented on the maker's pages, has no peer-reviewed journal publication — the maker's hosted report is the record.
• Amounts exist only inside a 57-page PDF marked "CONFIDENTIAL" on every page, which the maker nonetheless links publicly. The pages where buyers actually shop publish none.
• "FDA-approved ingredients" — the brand FAQ's safety answer uses this phrase. It is the maker's claim, not a fact we can verify, and no supplement ingredient is "FDA-approved" in the way the phrase implies; as the standard FDA disclaimer notes, these statements have not been evaluated by the Food and Drug Administration.
• The trial population was narrow: healthy adults 18–60 with subjective memory complaints, at least 12 years of education — excluding, among others, pregnant women and anyone with a condition or medication that could affect cognition.

Who Should Not Use It

The brand site publishes no safety section — its homepage instead claims "No Unwanted Side-Effects," and its only specific warning anywhere is on the ingredients page: people who are pregnant or could become pregnant should not take vinpocetine, one of the 13 ingredients (the maker itself notes vinpocetine is prescription-only in Germany). No medication-interaction, medical-condition, surgery or breastfeeding warnings appear on the brand pages; the advice to speak with your doctor first — especially about medication interactions — appears only on the maker's secondary retail store page. The trial itself excluded pregnant women, people with dementia or Alzheimer's, and users of a long list of medications. If you are pregnant or could become pregnant, take any prescription medication, or manage a medical condition, talk to a doctor before using BrainPill — the maker provides no guidance on any of this on the pages where it sells the product.

Where to Buy

Buy only from the official site so the guarantee applies: the official BrainPill store. One month is $69.95 (MSRP $79.95); the maker's order page lists 2 bottles at $130.95, 3 at $192.95, 4 at $253.95, 5 at $310.95 and 6 at $354.95 (about $59.16 a bottle at six), with instalment options on the multi-bottle packs. Keep the dose arithmetic in view when choosing a pack: at the 4-capsules-a-day regimen the trial used, one box lasts about two weeks, not a month. The 67-day guarantee covers a promptly started trial at the implied retail dose. Disclosure: if you buy through our link, we may earn a commission at no extra cost to you.

FAQ

Has BrainPill been clinically tested?
Yes — genuinely, and that is rare here. The maker ran a randomized, double-blind, placebo-controlled 12-week trial of the finished formula (registered as NCT03198936, run by Vedic Lifesciences, sponsored by the maker's own entity) and hosts the full report on its site. Its primary working-memory result was significant at p=0.044; one measure (picture recognition) was no longer significant by day 84. The trial has not, on the maker's pages, been published in a peer-reviewed journal.

What dose was tested — and what dose do I take?
The trial used 4 capsules a day (2 twice a day, with meals). The maker publishes no directions for buyers on its web pages; a 60-capsule box sold as a one-month supply implies 2 a day — half the trialled dose. Follow your bottle's label, and know that the published results come from the higher regimen.

Why is vinpocetine missing from the trial?
We don't know, and neither the report nor the sales pages explain it. Vinpocetine is marketed as one of the 13 ingredients everywhere the product is sold, but the composition table in the maker's own trial report lists only 12 ingredients, and vinpocetine is not among them. Either the trialled formula differed from the marketed one, or the table is incomplete.

How much does it cost, and how long does a box last?
$69.95 for one box (MSRP $79.95), falling to about $59.16 a box at six. At the implied retail dose of 2 capsules a day, a 60-capsule box lasts a month; at the trialled 4 a day, about two weeks.

How long before it works?
The maker's pages give three answers: at least 30 days (homepage), 30 to 90 days (brand FAQ), and three to six months to "hit your stride" (its retail store). The trial itself ran 12 weeks. The guarantee is 67 days — judge inside it.

Are there side effects or people who should not take it?
In the trial, safety was comparable to placebo: 9 mild-to-moderate adverse events in total (3 on BrainPill, 6 on placebo), none serious. But the brand site publishes no safety section, claims "No Unwanted Side-Effects," and its one specific warning is that people who are pregnant or could become pregnant should not take vinpocetine. If you take medication or have a medical condition, consult a doctor first.

Also Consider

• GenuinePurity NMN — a different, longevity-pathway approach from the same maker family, with the opposite documentation profile: a single ingredient at a fully disclosed dose, a stated purity and a published batch report, but no finished-product trial.

Last reviewed: October 2026